Navigation Links
Tarpinian: Misclassification is Theft
Date:9/7/2007

WASHINGTON, Sept. 7 /PRNewswire-USNewswire/ -- Following is a statement by Change to Win Executive Director Greg Tarpinian on the misclassification of workers and today's signing of an executive order to prevent employee misclassification by New York Governor Eliot Spitzer:

Change to Win is a partnership of seven unions with six million members in the growth occupations and industries of the 21st century --- from retail to health care, from construction and transportation to food processing and hospitality --- we are organizing the workforce of the future, we are organizing to bring the American dream to the next generation of workers.

For workers that dream is a good job, economic security for the family and opportunity to earn a better life. Misclassification of workers as independent contractors --- directing and controlling the work, but refusing to take responsibility for those doing the work --- is a direct attack on that dream and the economic well-being of working families.

Through misclassification, employers effectively exempt themselves from labor and employment laws that are the foundation of American workplace standards --- from programs like unemployment insurance and workers compensation that provide economic protection for working families --- and, reverse more than a century of social progress. They would turn America into a third world country.

Millions of workers are currently misclassified and tens of millions more are threatened, if we do not actively and aggressively enact and enforce laws and regulations to stop the abuse of designating workers as contractors.

What does misclassification mean to a working family?

It means if you lose your job --- you don't get unemployment --- because you were not an employee.

It means if you get hurt on the job, you don't receive medical coverage or income protection through workers' compensation--because you are not a worker.

Let's be clear: misc
'/>"/>

SOURCE Change to Win
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Strange Theft Of HIV Infected Blood Leaves Authorities Puzzled
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Sedgwick CMS and UnitedHealth Group to Develop Integrated Disability, Medical, Workers' Compensation and Leave Administration Services for Employers 2Health News:Sedgwick CMS and UnitedHealth Group to Develop Integrated Disability, Medical, Workers' Compensation and Leave Administration Services for Employers 3Health News:Sedgwick CMS and UnitedHealth Group to Develop Integrated Disability, Medical, Workers' Compensation and Leave Administration Services for Employers 4Health News:New book presents comprehensive survey of research into the molecular basis of aging 2Health News:BBVA Chairman Francisco González announces the BBVA Frontiers of Knowledge Awards 2Health News:BBVA Chairman Francisco González announces the BBVA Frontiers of Knowledge Awards 3Health News:Fluoridated water for Queensland ... at last 2Health News:Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives 2Health News:Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives 3Health News:Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives 4Health News:Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives 5Health News:Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives 6Health News:Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives 7Health News:Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives 8
Breaking Medicine Technology:Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 2Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 3Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 4Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 5Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 6Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 7Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 8Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 9Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 10Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 11Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 12Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 13Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 14Heska Announces Extension of Credit Agreement With Wells Fargo 2Heska Announces Extension of Credit Agreement With Wells Fargo 3Prodigy AutoCode Now Available in 116 Harris Teeter Pharmacies 56299 1Prodigy AutoCode Now Available in 116 Harris Teeter Pharmacies 56299 2Onyx Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference 13865 1Stand Up for Health Care 21 A Labor Day Message From RWDSU President Stuart Appelbaum 56294 1Stand Up for Health Care 21 A Labor Day Message From RWDSU President Stuart Appelbaum 56294 2Stand Up for Health Care 21 A Labor Day Message From RWDSU President Stuart Appelbaum 56294 3
Other Medicine Technology:Interim Response and Safety Analyses Support Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma 2Interim Response and Safety Analyses Support Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma 3Interim Response and Safety Analyses Support Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma 4Interim Response and Safety Analyses Support Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma 5Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy 2Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy 3Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy 4Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy 5